Slovakia Approves Medicine Reimbursement Amendment, Improves Drug Access
What happened
The Parliament of Slovakia approved an amendment to the law governing the reimbursement of medicines. This new legislation introduces a legal entitlement for patients to exceptional medicines and establishes uniform criteria for all health insurance companies. The changes also aim to speed up market access for new medicines and reduce the illegal re-export of pharmaceuticals.
From enrsi.stvr.sk
Why it matters
The amendment fundamentally changes the process by which specialized drugs are covered by public health insurance in Slovakia. By setting uniform legal criteria and improving market access, the law alters the regulatory environment for pharmaceutical providers.
From enrsi.stvr.sk
Who's involved
- Kamil ŠaškoAnnounced the changes regarding medicine reimbursement at a press conference
- SlovakiaThe country where the new medicine reimbursement legislation was approved
- Minister of Health of the Slovak RepublicThe minister associated with the health changes and new legislation
- National CouncilThe parliamentary body that approved the medicine reimbursement amendment
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- Bausch HealthSpeculative
Bausch Health might see increased revenue due to improved market access and the removal of financial caps for exceptional medicines.